EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)

Study Title
EVOLVE 48: A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of the SYNERGY 48 mm Everolimus-Eluting Platinum Chromium Coronary Stent System for the Treatment of Atherosclerotic Lesion(s)
Sponsor Name
Boston Scientific Corporation
NCT Number
NCT03350542
IDE Number
G170282
CMS Approval Date
2018-05-07
Category
B

https://clinicaltrials.gov/ct2/show/NCT03350542